Results 51 to 60 of about 510,668 (221)

#CardioOncology: Twitter chat as a mechanism for increasing awareness of heart health for cancer patients

Cardio-Oncology, 2020
Consideration of heart health for cancer survivors is increasingly important, as improved cancer survivorship has resulted in a growing number of survivors affected by cardiovascular disease.
Claire C. Conley, Neha G. Goyal, Sherry-Ann Brown   +2 more
doaj   +1 more source

A virtual-hybrid approach to launching a cardio-oncology clinic during a pandemic

Cardio-Oncology, 2021
Background As cardiovascular disease is a leading cause of death in cancer survivors, the new subspecialty of Cardio-Oncology has emerged to address prevention, monitoring, and management of cardiovascular toxicities to cancer therapies.
Sherry-Ann Brown, Sahishnu Patel, David Rayan, Svetlana Zaharova, Mingqian Lin, Tarek Nafee, Bipin Sunkara, Ragasnehith Maddula, James MacLeod, Krishna Doshi, Joshua Meskin, David Marks, Jorge Saucedo   +12 more
doaj   +1 more source

Dispensing of actionable pharmacogenetic drugs among adults receiving cardiovascular disease medications in the Northern Netherlands: A serial cross‐sectional study

Clinical Pharmacology &Therapeutics, EarlyView.
The extent of pharmacogenetic (PGx) drug dispensing among Dutch adults receiving medications for cardiovascular disease (CVD) is unknown. Using the University of Groningen IADB.nl pharmacy database, we performed a serial cross‐sectional study (2019–2023) to estimate the annual prevalence of PGx drug dispensing and annual rates of initiation.
Zhuolin Zhang, Guiling Zhou, Jens H. J. Bos, Eelko Hak, Talitha Feenstra, Frank Klont   +5 more
wiley   +1 more source

Cardio-oncology strain assessment for all?

, 2019
Recording of presentation given by William L. Border with the title 'Cardio-oncology strain assessment for all?', presented on Thursday, 14 March 2019 as part of the Inaugural PROTEA (Partnerships for Children with Heart Disease in Africa) Workshop in ...
William L. Border (7524320)
core   +1 more source

Proceedings From the Global Cardio-Oncology Summit

JACC. CardioOncology, 2019
The discipline of cardio-oncology has expanded at a remarkable pace. Recent developments and challenges to clinicians who practice cardio-oncology were presented at the Global Cardio-Oncology Summit on October 3 to 4, 2019, in São Paulo, Brazil. Here, we
Daniel J. Lenihan, MD, Michael G. Fradley, MD, Susan Dent, MD, Christine Brezden-Masley, MD, PhD, Joseph Carver, MD, Roberto Kalil Filho, MD, PhD, Tomas G. Neilan, MD, MPH, Anne Blaes, MD, Chiara Melloni, MD, MHS, Joerg Herrmann, MD, Saro Armenian, DO, MPH, Paaladinesh Thavendiranathan, MD, SM, Gregory T. Armstrong, MD, MSCE, Bonnie Ky, MD, MSCE, Ludhmila Hajjar, MD   +14 more
doaj   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil   +12 more
wiley   +1 more source

Cardio-oncology : where do we stand for in Belgium? [PDF]

, 2020
: Cardiovascular disease (CVD) and cancer represent the two main causes of death in industrialised countries. Both share common risk factors (diabetes, obesity, hypertension, diet, smoking, etc.).
Claeys, Marc, De Pauw, Michel, Claeys, Marc J., Lancellotti, Patrizio   +3 more
core   +1 more source

CardiLect: A combined cross‐species lectin histochemistry protocol for the automated analysis of cardiac remodelling

ESC Heart Failure, Volume 12, Issue 2, Page 1398-1415, April 2025.
Abstract Background Cardiac remodelling, a crucial aspect of heart failure, is commonly investigated in preclinical models by quantifying cardiomyocyte cross‐sectional area (CSA) and microvascular density (MVD) via histological methods, such as immunohistochemistry.
Tamás G. Gergely, Tamás Kovács, Andrea Kovács, Viktória E. Tóth, Nabil V. Sayour, Gábor M. Mórotz, Csenger Kovácsházi, Gábor B. Brenner, Zsófia Onódi, Balázs Enyedi, Domokos Máthé, Przemyslaw Leszek, Zoltán Giricz, Péter Ferdinandy, Zoltán V. Varga   +14 more
wiley   +1 more source

Core outcome set for cardio-oncology : development of a set of outcomes for the cardiovascular assessment and monitoring of cancer patients and survivors

Publisher Copyright: © 2024 The Author(s).Aims There is an increasing awareness of the evidence-based selection of outcomes to be measured in clinical trials and clinical practice.
Cardio-oncology expert panel
core   +2 more sources

Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different?

ESC Heart Failure, Volume 12, Issue 2, Page 1447-1454, April 2025.
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo, Daniela Di Lisi, Antonio Cannatà, Federica Manfrè, Celeste Vullo, Marco Santoro, Ciro Botta, Salvatrice Mancuso, Sergio Siragusa, Alfredo Ruggero Galassi, Giuseppina Novo   +10 more
wiley   +1 more source